0001579241-26-000007
SEC filingAllegion plc reported strong financial performance for fiscal year 2025, ending December 31, 2025. The company achieved net revenues of $4.07 billion, generating operating income of $859.5 million and net earnings attributable to Allegion plc of $643.8 million. This resulted in earnings per share of $7.00. The company maintained a solid balance sheet with total assets of $5.22 billion, including cash and cash equivalents of $356.2 million, while managing total liabilities of $3.16 billion, which included long-term debt of $1.98 billion. Operating activities provided robust cash flow of $783.8 million, though significant investing activities for business acquisitions ($592.2 million) and capital expenditures ($98.1 million) resulted in net cash used in investing activities of $685.5 million. The company returned capital to shareholders through $175.3 million in dividends paid and $80.0 million in share repurchases. The comprehensive income attributable to Allegion plc was $769.8 million, reflecting positive currency translation adjustments.
Allegion plc delivered solid financial results for the fiscal year ended December 31, 2025. The company reported net revenues of $4.07 billion. From this revenue base, it achieved operating income of $859.5 million and net earnings attributable to Allegion plc of $643.8 million. Earnings per share were $7.00. Total comprehensive income attributable to Allegion plc was $769.8 million, which includes other comprehensive income of $126.0 million, primarily driven by a $130.2 million currency translation gain. The company's effective tax rate was approximately 16.2%, calculated from the provision for income taxes of $124.6 million on earnings before income taxes of $768.4 million.
The provided financial data does not include a breakdown of revenue by segment, product line, or geography. The analysis is therefore limited to the consolidated revenue figure of $4.07 billion. No specific growth drivers, such as pricing, volume, or acquisitions, are quantified in the provided data. The cost of goods sold was $2.23 billion, resulting in a gross profit of $1.84 billion.
The company demonstrated healthy profitability metrics. The gross margin was 45.2%, calculated from gross profit of $1.84 billion on revenue of $4.07 billion. The operating margin was 21.1%, derived from operating income of $859.5 million. Selling and administrative expenses totaled $978.8 million, representing 24.0% of revenue. Interest expense was $101.0 million. The net income margin was 15.8% ($643.8M / $4.07B).
Cash flow from operations was strong at $783.8 million, significantly exceeding net earnings of $643.8 million, aided by non-cash add-backs like $133.2 million in depreciation and amortization. Free cash flow, calculated as operating cash flow ($783.8M) less capital expenditures ($98.1M), was $685.7 million. Investing activities used $685.5 million, predominantly for the acquisition of businesses ($592.2M). Financing activities used $266.7 million, including dividend payments ($175.3M), share repurchases ($80.0M), and net debt repayments ($25.5M). The balance sheet shows total assets of $5.22 billion, with current assets of $1.39 billion. Total liabilities were $3.16 billion, including long-term debt of $1.98 billion. Total equity stood at $2.07 billion, resulting in a debt-to-equity ratio of approximately 0.96. The company ended the period with $288.0 million in cash and cash equivalents.
The provided financial data and document content do not contain any forward-looking statements, management guidance, disclosed strategic priorities, or specific risk factors. Therefore, no outlook information is available for analysis based solely on the provided source material.